Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02221557 · ClinicalTrials.gov registry record · NA
Case Series of New Alloplastic Bone Graft Material
A NA study, sponsored by Sunstar Americas.
- Completed
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT02221557: Completed NA study, sponsored by Sunstar Americas.
NCT02221557 is a NA study that has completed, run by Sunstar Americas. The registered enrollment target is 8 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02221557, a NA study, has completed, sponsored by Sunstar Americas.
- COMPLETED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
A case series to compare the handling and effectiveness of two different treatment approaches using a new alloplastic bone graft material in ridge preservation compared to allograft existing historical data.
Primary Outcome
Radiographic measurement was taken at most-middle portion of the grafted site, perpendicular to the line drawn from reference point (e.g. adjacent tooth/teeth Cement-Enamel Junction (CEJ) or margin of the restoration).
Interventions
- DEVICE easy-graft (beta-Tricalcium Phosphate)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2015-03 |
| Est. Completion | 2016-06 |
| Phase | NA |
What the finished NCT02221557 record still lists
NCT02221557 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which easy-graft (beta-Tricalcium Phosphate) is the first listed.
NCT02221557 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02221557 about?
NCT02221557 is a clinical study titled "Case Series of New Alloplastic Bone Graft Material". A case series to compare the handling and effectiveness of two different treatment approaches using a new alloplastic bone graft material in ridge preservation compared to allograft existing historical data.
What is the current status of trial NCT02221557?
This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2015-03. Estimated completion is 2016-06.
What interventions are being tested in trial NCT02221557?
The interventions under investigation include: easy-graft (beta-Tricalcium Phosphate) (DEVICE).
Who is sponsoring clinical trial NCT02221557?
This trial is sponsored by Sunstar Americas, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02221557's enrollment target sits among peer trials
8 1976th of 2000 higher than 19 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia